Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow SI-BONE, Inc.

Get SEC filing alerts via email and in your feed for SI-BONE, Inc.

SIBN

SI-BONE, Inc.

About SI-BONE, Inc.

SI-BONE, Inc. develops minimally invasive surgical implant systems for musculoskeletal disorders of the sacropelvic anatomy, focusing on sacroiliac joint dysfunction, pelvic fixation, and fractures. Its core products include patented titanium implants and related instruments, supported by extensive clinical evidence. Serving global markets, the company emphasizes innovative solutions, physician training, and strong regulatory compliance to improve patient outcomes in spine and pelvic surgeries.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from SI-BONE, Inc.

1
1
SI-BONE, Inc. SI-BONE Reports $52.6 Million Revenue in Q1 2026, 11.2% Increase Year-Over-Year

Via official filing (AI summary) | 24 days ago | 0 comments

2
1
SI-BONE, Inc. SI-BONE Reports 20.2% Revenue Growth to $200.9 Million for Fiscal Year 2025

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
SI-BONE, Inc. SI-BONE Reports 20.6% Revenue Growth to $48.7 Million in Q3 2025

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
SI-BONE, Inc. SI-BONE Reports 21.7% Revenue Growth to $48.6 Million in Q2 2025

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
SI-BONE, Inc. SI-BONE Reports 25% Revenue Growth to $47.3 Million in Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
SI-BONE, Inc. SI-BONE Reports 20% Revenue Growth to $167.2 Million for Fiscal Year 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

7
1
SI-BONE, Inc. SI-BONE Reports 19% Revenue Growth, Improved Operating Efficiency in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments